2024年3月19日 · These medications include Ozempic and Mounjaro (which are approved to treat Type 2 diabetes, but are also used off-label for weight loss) and Wegovy and Zepbound (which are approved as anti ...

2025年1月23日 · With the rise of weight loss drugs like Ozempic and Wegovy, a slew of celebrities have come forward and admitted to taking them in a bid to slim down. One such A-lister is Oprah Winfrey, who ...

2023年12月14日 · Winfrey is aware of the buzz around her body size, especially as the use of medications like Wegovy, Ozempic and Mounjaro for weight loss has surged in popularity. But she stresses it has not...

2024年3月19日 · Oprah also talked with patients who have tried weight-loss medications like Ozempic and Mounjaro. “It is a very personal topic for me and for the hundreds of millions of people impacted around the globe who have for years struggled with weight and obesity,” Oprah says about the special.

Oprah Winfrey says taking a GLP-1 drug such as Ozempic and Wegovy has changed her entire perspective on “thin people.” The media icon, 70, took to her podcast last week to share her experience ...

2024年3月21日 · Oprah Winfrey returned to TV with a special focused on how weight-loss drugs like Wegovy and Zepbound are changing the health of people with obesity.

2025年1月23日 · Discover how Oprah Winfrey's experience with GLP-1 medications like Ozempic reshaped her understanding of weight loss and challenged societal perceptions.

3 天之前 · Is Oprah Winfrey taking Ozempic? The talk show host says she's using a weight-loss drug after appearing much slimmer at "The Color Purple" premiere.

2024年3月19日 · On Monday night, Oprah Winfrey aired her latest prime-time special, Shame, Blame and the Weight Loss Revolution. The special focused on the recent wave of weight-loss drugs like Ozempic and Wegovy and saw Oprah talk …

2024年3月18日 · Oprah Winfrey, a longtime figure in the national conversation about dieting and weight bias, devoted an hourlong prime-time special on Monday to the rise of weight loss drugs. Her goal, she...